Average Co-Inventor Count = 1.43
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Albert Einstein College of Medicine (12 from 504 patents)
2. Sloan-kettering Institute for Cancer Research (2 from 512 patents)
12 patents:
1. 12263203 - BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies
2. 12252538 - Monoclonal antibodies against IgV domain of B7-H3 and uses thereof
3. 12221489 - Antibodies to human B7x for treatment of metastatic cancer
4. 12145989 - Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof
5. 12134645 - Monoclonal antibodies against human tim-3
6. 11377494 - Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof
7. 11261253 - HHLA2 as a novel inhibitor of human immune system and uses thereof
8. 10882893 - TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies
9. 10689432 - B7X and its derivatives for treating and preventing cardiovascular disease
10. 10280208 - TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies
11. 10093737 - HHLA2 as a novel inhibitor of human immune system and uses thereof
12. 9447186 - Antibodies to human B7x for treatment of metastatic cancer